ENDRA Life Sciences (NDRA) Total Debt (2016 - 2023)

ENDRA Life Sciences (NDRA) has reported Total Debt for 7 consecutive years, with $56968.0 the latest figure, recorded in Q4 2023.

• On a quarterly basis, Total Debt changed 0.0% year-over-year to $56968.0 in Q4 2023; TTM through Dec 2023 was $56968.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $56968.0, changed 0.0% from the prior year.
• Total Debt was $56968.0 for Q4 2023 at ENDRA Life Sciences, roughly flat from $56968.0 in the prior quarter.
• Over five years, Total Debt peaked at $614677.0 in Q2 2021 and troughed at $28484.0 in Q1 2021.
• A 5-year average of $346159.1 and a median of $337603.0 in 2020 frame the typical range for Total Debt.
• The widest YoY moves for Total Debt: up 1690.84% in 2022, down 89.58% in 2022.
• Over 5 years, Total Debt stood at $298069.0 in 2019, then soared by 104.31% to $608992.0 in 2020, then slipped by 10.24% to $546631.0 in 2021, then slumped by 89.58% to $56968.0 in 2022, then changed by 0.0% to $56968.0 in 2023.
• The last three Total Debt figures came in at $56968.0 (Q4 2023), $56968.0 (Q3 2023), and $338122.0 (Q2 2023), per Business Quant data.